NCT01928290View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

November 8, 2013

Primary Completion Date

December 3, 2018

Study Completion Date

October 28, 2019

Conditions
Stomach NeoplasmsEsophageal Neoplasms
Interventions
DRUG

Irinotecan

DRUG

Trastuzumab

DRUG

Oxaliplatin

DRUG

Leucovorin

DRUG

Fluorouracil

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT01928290 - Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer | Biotech Hunter | Biotech Hunter